Valuation: 10x Genomics, Inc.

Market Cap 5.79B 5.02B 4.7B 4.3B 8.12B 551B 8.23B 55.03B 21.6B 276B 21.74B 21.26B 917B P/E 2026 *
-56.2x
P/E 2027 * -65.3x
Enterprise Value 5.31B 4.61B 4.32B 3.95B 7.45B 506B 7.55B 50.49B 19.81B 253B 19.94B 19.51B 841B EV / Sales 2026 *
8.65x
EV / Sales 2027 * 7.81x
Free-Float
90.53%
Yield 2026 *
-
Yield 2027 * -
1 day-3.92%
1 week-7.75%
Current month-3.53%
1 month+14.00%
3 months+100.53%
6 months+145.03%
Current year+179.58%
1 week 44.79
Extreme 44.7901
49.19
1 month 35.12
Extreme 35.12
50.34
Current year 15.9
Extreme 15.9
50.34
1 year 11.16
Extreme 11.16
50.34
3 years 6.78
Extreme 6.78
57.9
5 years 6.78
Extreme 6.78
191.15
10 years 6.78
Extreme 6.78
208.99
Manager TitleAgeSince
Chief Executive Officer 49 2012-07-01
President 51 2012-09-30
Director of Finance/CFO 51 2024-08-11
Director TitleAgeSince
Director/Board Member 51 2012-07-01
Director/Board Member 49 2012-07-01
Chairman 68 2013-07-31
Date Insider Type Main position Quantity % Market Cap.
2/26/26 Free

Founder

88,816 0.0763%
2/26/26 Free

Chief Financial Officer

106,579 0.0915%
2/26/26 Free

Founder

157,895 0.1356%
Change 5-day change 1-year change 3-year change Capi.($)
-3.92%-7.75%+260.19%-18.63% 6.03B
-3.43%+3.43%+253.40%+316.66% 21.9B
+0.83%+0.90%-40.77%-23.33% 9.77B
-0.42%+0.07%+94.85%+33.53% 6.61B
+0.84%-3.71%-15.73%-16.55% 5.42B
+21.58%+24.30%-30.92% - 4.65B
-0.61%+7.98%-10.72%-21.79% 4.58B
+2.41%+14.67%+83.14%+100.70% 4.33B
-1.99%-4.30%-20.21%-39.26% 2.76B
+0.10%+1.05%-58.46%+158.47% 1.36B
Average +1.54%+3.25%+51.48%+54.42% 6.74B
Weighted average by Cap. +0.20%+3.45%+108.18%+114.23%

Financials

2026 *2027 *
Net sales 614M 533M 499M 456M 862M 58.49B 873M 5.84B 2.29B 29.23B 2.31B 2.26B 97.28B 671M 583M 546M 499M 942M 63.96B 955M 6.38B 2.51B 31.96B 2.52B 2.47B 106B
Net income -104M -90.66M -84.89M -77.65M -147M -9.95B -149M -993M -390M -4.97B -392M -384M -16.55B -90.68M -78.69M -73.69M -67.41M -127M -8.64B -129M -862M -338M -4.32B -340M -333M -14.37B
Net Debt -478M -415M -389M -356M -671M -45.56B -680M -4.55B -1.78B -22.77B -1.8B -1.76B -75.77B -548M -476M -445M -407M -769M -52.21B -779M -5.21B -2.04B -26.08B -2.06B -2.01B -86.82B
Logo 10x Genomics, Inc.
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
Employees
1,178
Date Price Change Volume
26-08-06 US$45.60 -3.92% 2,508,928
26-08-05 US$47.46 -0.84% 2,498,003
26-08-04 US$47.86 +1.81% 2,655,384
26-08-03 US$47.01 -0.55% 3,397,348
26-07-31 US$47.27 -4.37% 2,869,326
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
45.60USD
Average target price
41.54USD
Spread / Average Target
-8.91%

Quarterly revenue - Rate of surprise